Skip to main content
. 2021 Feb 23;73(12):2166–2174. doi: 10.1093/cid/ciab168

Table 1.

Prevalence and 95% Confidence Interval (CI) of Clinical Events Among Ebola Virus Disease Survivors Over Time (Postdischarge from Ebola Treatment Center) in PostEboGui Cohort

24 months after ETC discharge 36 months after ETC discharge 48 months after ETC discharge
Clinical Sequelae (%) All (95% CI) Adults (95% CI) Children (95% CI) P value All (95% CI) Adults (95%CI) Children (95% CI) P value All (95% CI) Adults (95% CI) Children (95% CI) P value
Abdominala 26.77 (22.64–30.91) 23.24 (17.80–28.68) 40.77 (33.08–48.45) .000 22.85 (20.91–24.79) 21.45 (19.90–23.01) 30.20 (25.12–35.28) .000 17.08 (15.38–18.78) 14.67 (11.90–17.44) 30.68 (21.40–39.96) .000
Neurologicalb 46.30 (42.34–50.27) 44.47 (40.51–48.42) 53.88 (43.91–63.84) .000 34.25 (31.61–36.90) 34.31 (31.05–37.57) 33.94 (27.82–40.07) .721 27.68 (24.31–31.05) 27.15 (22.95–31.34) 30.55 (20.68–40.41) .016
Ocularc 9.17 (7.07–11.27) 8.60 (6.55–10.65) 11.42 (8.41–14.42) .003 5.59 (4.73–6.45) 6.07 (4.99–7.14) 3.08 (1.84–4.32) .000 6.07 (5.15–7.00) 6.41 (5.17–7.65) 4.24 (2.26–6.23) .005
Musculoskeletald 35.34 (32.20–38.47) 37.64 (34.33–40.95) 25.70 (19.26–32.15) .000 22.44 (20.01–24.88) 24.06 (21.82–26.31) 13.96 (9.16–18.76) .000 16.82 (14.55–19.08) 18.91 (16.35–21.47) 5.80 (1.96–9.65) .000
Generale 50.70 (47.26–54.14) 50.37 (47.11–53.64) 51.98 (43.37–60.60) .326 33.16 (31.26–35.07) 33.75 (31.05–36.46) 30.04 (27.17–32.91) .000 25.35 (23.63–27.07) 25.01 (22.03–27.98) 27.15 (19.19–35.11) .137

Abbreviation: ETC, Ebola Treatment Center.

aAbdominal = abdominal or pelvic pain, gastritis.

aNeurological = headache, dizziness and other (neurosensitive disorders, neuromotor disorders, behavioral problems).

aOcular = conjunctivitis, iridocyclitis, cataract, glaucoma, vision problems, ocular pain.

aMusculoskeletal = neck pain, back pain, joint pain, myalgia.

aGeneral = fever, fatigue, anorexia.